Investigator Financial Disclosure Revised Rule Limits Retrospective Reports
This article was originally published in The Tan Sheet
Executive Summary
Retrospective collection of financial information about clinical investigators' equity interests in publicly traded companies has been eliminated from FDA's final rule on Financial Disclosure by Clinical Investigators.